A real-life , prospective, single-center study analyzing any improvements in patients' asthma control with the use of Tezspire
Latest Information Update: 28 Mar 2024
At a glance
- Drugs Tezepelumab (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 26 Feb 2024 Results(n=20) assessing subjective and objective patient asthma outcomes pre vs. post Tezepelumab-ekko treatment, and to describe patient characteristics, presented at the 2024 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
- 14 Apr 2023 New trial record
- 27 Feb 2023 Results presented at the 2023 Annual Meeting of the American Academy of Allergy, Asthma and Immunology